CLDN2 and heart failure: The result suggests that allopurinol-induced oxidative stress might decrease urinary osmolality, possibly via the reduction of aquaporin 1 and/or claudin-2 in proximal renal tubule in patients with heart failure, and topiroxostat might have potential advantages of not worsening oxidative stress.